Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Director bought 5,800 shares at $45.51 ($263,970)
  4. 4 Grant or award Chief Financial Officer acquired 10,303 shares (grant or award)
  5. 4 Open-market buy CEO bought 25,000 shares at $46.27 ($1,156,800)
  6. 4 Open-market sale CEO sold 1,262 shares at $66.65 ($84,112)
  7. 4 Open-market sale Chief Financial Officer sold 1,568 shares at $78.27 ($122,727)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale EVP/Chief Scientific Officer sold 10,000 shares at an average $63.22 ($632,156)
  11. 4 Open-market sale EVP/Chief Scientific Officer sold 10,000 shares at $45.00 ($450,000)
  12. 4 Open-market sale EVP/Chief Scientific Officer sold 20,000 shares at $40.02 ($800,400)
  13. 4 Grant or award EVP/Chief Medical Officer acquired 20,000 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale EVP/Chief Scientific Officer sold 228 shares at $31.21 ($7,116)
  16. 4 Open-market sale EVP/Chief Scientific Officer sold 3,000 shares at $31.39 ($94,170)
  17. 4 Open-market sale CEO sold 1,976 shares at $36.66 ($72,440)
  18. 4 Open-market sale EVP/Chief Scientific Officer sold 10,000 shares at $35.29 ($352,900)
  19. 4 Open-market sale EVP/Chief Scientific Officer sold 10,238 shares at an average $37.41 ($383,028)
  20. 4 Open-market sale EVP/Chief Scientific Officer sold 3,000 shares at $32.22 ($96,660)

Page 9 of 18 · 351 filings